Neomorphincis A Biotechnology Company Based In San Diegocaliforniafounded In 2020The Company Is Dedicated To Addressing Significant Challenges In Human Health By Developing Innovative Medicines Targetingundruggableproteinsneomorph S Team Includes Experts In Protein Degradation And Molecular Glueswith Notable Scientific Founders Such As Phil Chamberlaindphiland Eric Fischerphd The Company Specializes In Targeted Protein Degradation Technologiesparticularly Molecular Glue Degraderswhich Allow For The Targeting Of Proteins That Traditional Drugs Cannot Addressneomorph S Platform Has Potential Applications In Various Disease Areasincluding Oncologythe Company Has Established Collaborationsincluding A Partnership With Abbvie To Develop Molecular Glue Degraders For Oncology And Immunologyand Works Closely With The Center For Protein Degradation At The Dana Farber Cancer Instituteneomorph Has Secured Significant Fundingincluding A $109 Million Series A Financing To Support Its Research And Development Efforts
No conferences found for this company.
| Company Name | Neomorph Inc |
| Country |
United States
|
| Address | 5590 Morehouse Dr San Diego California 92121 United States |
| Telephone | Login to View |
| Login to View |
